Quick, simple nasal swab helps diagnose type of asthma in children
A new quick-and-easy nasal swab test for kids can diagnose the specific immune system drivers behind their asthma, ...
Screening for physical inactivity can cut risk of chronic illness, study suggests
Encouraging primary care physicians to screen patients for physical inactivity with a simple questionnaire can help identify ...
Hosted on MSN41m
Lilly's Zepbound approved by FDA for sleep apnea treatment
The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans ...
pharmaphorum22h
FDA starts review of Pfizer, Lilly’s non-opioid painkiller
After years in development, the FDA has started its review of Pfizer and Eli ... Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea ...
pharmaphorum22h
Lilly cuts $1bn deal for Centrexion’s non-opioid painkiller
Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront for rights to a non-opioid analgesic drug developed by US biotech Centrexion Therapeutics.
The New York Times22h
World News
And why didn’t it cut off Russia’s natural gas earlier? By Marc SantoraAndrew Higgins and Stanley Reed A transnational pipeline was shut down on Wednesday after Kyiv refused to renew a ...
The New York Times7h
New York Times - Top Stories
In New Orleans, Celebration Is Followed by Terror in the French Quarter The attack left 15 dead and about three dozen injured. The authorities described it as an act ...